Chris Tate
Structural biology of integral membrane proteins
cgt@mrc-lmb.cam.ac.uk
Personal group site
There are over 350 non-odorant GPCRs encoded by the human genome that are involved in hormone binding and transducing this signal to the cytoplasm, resulting in the activation of G protein pathways and eventually eliciting a cellular response. The key role of GPCRs in signal transduction pathways makes them ideal as drug targets with many classes of small molecule drugs, such as beta blockers or anti-asthma treatments, either inhibiting or activating these receptors. There are many potential problems in determining the structure of membrane proteins, but we have recently developed a strategy based on rational mutagenesis to improve the thermostability of GPCRs, which has made crystallisation and structure determination far more tractable. We initially solved the structure of the β1-adrenergic receptor to 2.7 Å resolution with an antagonist bound and recently structures have been solved with agonists bound. Subsequent work will focus on determining the structures of different conformational states of the β1, adenosine A2A and neurotensin receptors, bound to G proteins and arresting.


Transporters are essential for the uptake and efflux of solutes across the membrane and many are potential drug targets. For example, the serotonin transporter is the major binding site in the brain for antidepressant drugs, amphetamines and cocaine. In contrast, multidrug transporters in bacteria and parasites actively pump antibiotics, antiseptics or other toxic agents out of the cell, allowing them to survive and cause diseases that are difficult to treat and hence often lead to death. Understanding the structures of a variety of transporters and how they function will facilitate the development of better therapeutic agents. Work will focus on the serotonin transporter and the E. coli multidrug transporter EmrE.

[3]: light blue squares, dodecylmaltoside; dark blue triangles, decylmaltoside; green circles,
nonylglucoside; ochre diamonds, LDAO; red inverted triangles, octylglucoside.
Wild-type β1AR precipitated in the presence of LDAO, NG and OG,
so it was not possible to measure its thermostability in these detergents.
Selected Papers
- Lebon, G., Warne, T., Edwards, P.C., Bennett, K., Langmead, C.J., Leslie A.G.W. and Tate C.G. (2011)
Agonist-bound structures of the adenosine A2A reveals common features of GPCR activation.
Nature 474: 521-525. - Warne, T., Moukhametzianov, R., Baker, J.G., Nehme, R., Edwards, P.C., Henderson, R., Leslie, A.G.W., Schertler, G.F.X. and Tate, C.G. (2011)
The structural basis for agonist and partial agonist action on a β1-adrenergic receptor.
Nature 469: 241-244. - Warne, T., Serrano-Vega, M. J., Baker, J. G., Moukhametzianov, R., Edwards, P. C., Henderson, R., Leslie, A. G., Tate, C. G. and Schertler, G. F. (2008)
Structure of a β1-adrenergic G-protein-coupled receptor.
Nature 454: 486-491.
Group Members
- Pat Edwards
- Jade Li
- Antony Warne
- Juni Andrell
- Byron Carpenter
- Rony Nehme
- Jennifer Pacyna
- David Wright
- Simone Weyand